Meadow Creek Investment Management LLC Sells 5,060 Shares of Colgate-Palmolive (CL)

Meadow Creek Investment Management LLC trimmed its holdings in Colgate-Palmolive (NYSE:CL) by 4.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 114,664 shares of the company’s stock after selling 5,060 shares during the quarter. Meadow Creek Investment Management LLC’s holdings in Colgate-Palmolive were worth $8,651,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Jacobi Capital Management LLC increased its stake in shares of Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after acquiring an additional 803 shares during the last quarter. Virtue Capital Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $104,000. Krilogy Financial LLC grew its position in shares of Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after purchasing an additional 289 shares during the period. Captrust Financial Advisors acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at approximately $122,000. Finally, Bruderman Asset Management LLC acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at approximately $126,000. 73.67% of the stock is owned by institutional investors and hedge funds.

How to Become a New Pot Stock Millionaire

CL has been the subject of several research analyst reports. Deutsche Bank assumed coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price objective for the company. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a research report on Tuesday, December 19th. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Tuesday, December 19th. Jefferies Group reissued a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a report on Friday, January 26th. Finally, BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $77.76.

CL stock opened at $71.64 on Friday. The firm has a market cap of $62,717.16, a price-to-earnings ratio of 24.96, a PEG ratio of 2.65 and a beta of 0.74. Colgate-Palmolive has a fifty-two week low of $67.86 and a fifty-two week high of $77.91. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.75. The company had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.75 EPS. equities analysts expect that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be issued a dividend of $0.42 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 2.35%. The ex-dividend date is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio is 55.75%.

In related news, insider Daniel B. Marsili sold 5,692 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $70.19, for a total value of $399,521.48. Following the sale, the insider now directly owns 41,677 shares of the company’s stock, valued at $2,925,308.63. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Patricia Verduin sold 1,572 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $70.17, for a total value of $110,307.24. Following the completion of the sale, the chief technology officer now directly owns 50,675 shares in the company, valued at $3,555,864.75. The disclosure for this sale can be found here. Over the last three months, insiders have sold 455,707 shares of company stock worth $32,443,427. 1.02% of the stock is currently owned by insiders.

WARNING: “Meadow Creek Investment Management LLC Sells 5,060 Shares of Colgate-Palmolive (CL)” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/07/meadow-creek-investment-management-llc-trims-holdings-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply